𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Imatinib mesylate as a cause of acute liver failure

✍ Scribed by Timothy J.S. Cross; Catherine Bagot; Bernard Portmann; Julia Wendon; D. Gillett


Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
151 KB
Volume
81
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.

✦ Synopsis


A 46-year-old patient diagnosed with chronic myeloid leukemia in whom cytogenetic and molecular remission had never been achieved was commenced on Imatinib Mesylate (GleevecΓ’, Novartis Pharmaceuticals Corp., East Hanover, NJ). After 18 months of treatment, she developed abnormal liver function tests and subsequently acute liver failure, requiring transfer to the regional liver unit. The patient proceeded to liver transplantation but later died. The explanted liver had histological features of severe hepatic necrosis. This is the first case described of fatal hepatic necrosis in a patient who has have been on long-term imatinib therapy. This may have implications for long-term use of the drug and emphasizes the need for regular monitoring of liver function. Am.


πŸ“œ SIMILAR VOLUMES


Unrecognized acetaminophen toxicity as a
✍ Niraj Khandelwal; Laura P. James; Corron Sanders; Anne M. Larson; William M. Lee πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 158 KB πŸ‘ 1 views

Despite extensive investigations, the cause of liver injury in 14% of patients with acute liver failure remains unknown (indeterminate). In a pilot study using a novel assay, highly specific acetaminophen-cysteine adducts were detected in 7 of 36 indeterminate patients (19%). To extend these observa

Acute liver failure: Summary of a worksh
✍ William M. Lee; Robert H. Squires Jr; Scott L. Nyberg; Edward Doo; Jay H. Hoofna πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 473 KB πŸ‘ 1 views

Acute liver failure (ALF) is a rare but challenging clinical syndrome with multiple causes; a specific etiology cannot be identified in 15% of adult and 50% of pediatric cases. The course of ALF is variable and the mortality rate is high. Liver transplantation is the only therapy of proven benefit,

An Assessment of Orthotopic Liver Transp
✍ Roger Williams; A. E. S. Gimson πŸ“‚ Article πŸ“… 1984 πŸ› John Wiley and Sons 🌐 English βš– 337 KB

Mortality of fulminant hepatic failure with standard supportive therapy is high (80 to 85%), but unfortunately most patients present to hospital already in Grade IV encephalopathy with severe liver dysfunction, and many have secondary organ damage. If seen earlier, during Grade III encephalopathy, r

Blood lactate as a prognostic marker in
✍ Lars E. Schmidt; Fin Stolze Larsen πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 67 KB πŸ‘ 1 views

Background: Although the King's College Hospital (KCH) selection criteria for emergency liver transplantation in paracetamolinduced acute liver failure are widely used, strategies to improve sensitivity and facilitate earlier transplantation are required. We investigated the use of arterial blood la